Loading
Loading
Review of Case Materials
Reviews records, documents, testimony, data, and other relevant materials and consults with counsel regarding technical issues related to the matter.
Provide Expert Analysis
Applies specialized knowledge and experience to evaluate the technical or professional issues involved.
Form Expert Opinions
Develops independent, supportable opinions based on the available evidence and relevant standards.
Prepare Expert Reports
Showing Results 0 of 0
No. Increased radiotracer uptake does not automatically indicate cancer because its meaning depends on the particular radiopharmaceutical and the biological process it reflects. For example, increased FDG uptake may occur with malignancy but can also be seen with infection, inflammation, normal physiological activity, muscle activity, and some benign conditions. The pattern should therefore be interpreted with the tracer’s expected biodistribution, anatomical location, clinical question, and other imaging or medical findings.
Nuclear medicine imaging uses radiotracers to provide information about physiological, metabolic, or molecular processes within the body. CT primarily provides detailed anatomical information, while MRI provides detailed structural and tissue characterization and can also provide certain functional information. Nuclear medicine can therefore demonstrate biological activity that complements the anatomical and tissue information obtained with CT or MRI.
PET/CT and SPECT/CT combine radiotracer information with anatomical CT images during the same hybrid examination. The CT component can help localize abnormal tracer activity to a particular organ or structure and improve interpretation of the nuclear medicine findings. Depending on the examination protocol, CT information may also be used for attenuation correction and image reconstruction in addition to providing anatomical detail.
Yes. The effect depends on the radiopharmaceutical and type of study. For FDG PET, factors such as recent food intake, blood glucose and insulin levels, strenuous exercise, medications, and recent procedures or treatment can alter tracer distribution or complicate interpretation. Other nuclear medicine examinations have different preparation and medication requirements, so the protocol used for the specific study should be considered when an unexpected uptake pattern is being analyzed.
Prepares clear, well-supported expert reports outlining methodology, analysis, findings, and opinions.
Provide Deposition Testimony
Explains findings and opinions under oath and responds to questioning during deposition testimony.
Testify in Court
Presents specialized findings and opinions clearly to judges, juries, arbitrators, or other decision-makers.
Radiopharmaceutical therapy uses a radioactive drug administered into the body that localizes to target tissue through biological, physiological, or molecular mechanisms and delivers radiation from within the patient. External-beam radiation therapy delivers radiation from a machine outside the body toward a defined treatment area. Brachytherapy is another form of radiation therapy in which a radioactive source is placed in or near the target tissue. These approaches differ in how radiation is delivered and may be used separately or as part of a broader treatment plan depending on the disease and clinical circumstances.
